Affichage 71 à 71 des 71 essais cliniques
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 |
|
ESSAIS CLINIQUES No essai ClinicalTrials.gov ID |
Phase | Coordonnateur(rice) | |
|---|---|---|---|
|
(EN) A Randomized, Double-blind, Multi-center, Phase III Study of AK112 or Placebo Combined With Pemetrexed and Carboplatin in Patients With EGFR-mutant Locally Advanced or Metastatic Non-squamous NSCLC Who Have Failed to EGFR-TKI Treatment
HARMONi NCT05184712  Actif en recrutement
|
INSTITUT UNIVERSITAIRE DE CARDIOLOGIE ET DE PNEUMOLOGIE DE QUEBEC - UL |
Brigitte Fortin 418-656-8711 poste 2639 |
Groupe d'étude en oncologie du Québec